Pharmexa In-Licenses Formulation Technology from ZYCOS for the AutoVac HER-2 DNA Therapeutic Cancer Vaccine HORSHOLM, Denmark, May 15, 2002 (PRIMEZONE) -- Pharmexa and ZYCOS today jointly announced that they have entered into an agreement to formulate Pharmexa's therapeutic DNA breast cancer vaccine in...

GPC Biotech Signs Agreement with ICOS to Manufacture Antibodies for Clinical Studies (with link) MARTINSRIED/MUNICH, Germany and BOSTON, Nov. 26, 2001 (PRIMEZONE) -- GPC Biotech AG (Frankfurt Stock Exchange:GPC) announced the signing of a development and manufacturing agreement with ICOS...